Skip to content
lifestyle.theroguemag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nanobiotix S.A.
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
June 2, 2026
Nanobiotix Joins the Euronext Tech Leaders Index
June 2, 2026
NANOBIOTIX Announces Closing of Global Offering
May 26, 2026
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 25, 2026
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
May 25, 2026
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
May 25, 2026
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 25, 2026
Nanobiotix Announces Launch of Global Follow-On Offering
May 25, 2026
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 24, 2026
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
May 22, 2026
1
2
Next Page
→